Macmillan Medical Communications welcomes Scott Carson as national sales manager

NewsGuard 100/100 Score

Macmillan Medical Communications (MMC) has welcomed Scott Carson as its new National Sales Manager. He will be reporting in to John Elduff, Senior VP of Sales, and will be based out of MMC’s corporate sales office in Philadelphia, PA.

Scott will be working with the Nature Clinical Practice (NCP) team and pharma clients to develop promotional campaigns across the entire NCP collection. Scott arrives at Nature from the Elsevier Pharma Sales group where he was instrumental in securing many large scale multi-faceted book and journal subscription deals.

“We are delighted that Scott has chosen to join the MMC team” commented John Elduff. “His expertise in developing promotional campaigns will be invaluable to us.”

Macmillan Medical Communications is a division of Macmillan Publishers Ltd, and is a strategic medical communications agency that provides customized products and services for partners in the pharmaceutical, healthcare, and biotechnology industries.

MMC’s bespoke packages target the specific needs of its partners’ audiences and communities. It uses the full range of communication and publishing strategies to develop high impact campaigns and services including novel internet-based approaches.

http://www.macmillanmedicalcommunications.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.